Differential expression of serum mir-363-3p in patients with polycystic ovary syndrome and its predictive value for their pregnancy

Table 1 Comparison of general data between PCOS group and control group

Indicators	Controls (n = 110)	PCOS (n = 126)	P value
Age (Year)	28.75 ± 2.41	28.64 ± 2.56	0.426
BMI (kg/m²)	23.41 ± 2.51	23.96 ± 2.72	0.103
SBP (mm Hg)	118.36 ± 13.14	119.73 ± 12.98	0.108
DBP (mm Hg)	72.48 ± 6.91	74.22 ± 6.82	0.465
FBG (mmol/L)	4.68 ± 0.46	5.01 ± 0.82	0.000
FINS (mIU/L)	7.16 ± 1.54	23.96 ± 4.91	0.000
HOMA-IR	1.57 ± 0.32	2.44 ± 0.95	0.000
LH (IU/L)	5.13 ± 1.75	12.31 ± 5.63	0.000
FSH (IU/L)	6.12 ± 1.81	7.88 ± 1.42	0.000
E₂ (pmol/L)	173.76 ± 40.51	102.61 ± 45.66	0.000
T (µg/L)	0.43 ± 0.20	0.89 ± 0.23	0.000
PRL (µg/L)	10.57 ± 4.27	13.85 ± 5.24	0.000
P (nmol/L)	0.81 ± 0.41	1.15 ± 0.49	0.000
AMH (ng/mL)	3.42 ± 1.36	9.59 ± 2.11	0.000
TC (mmol/L)	4.60 ± 0.36	4.95 ± 0.33	0.045
TG (mmol/L)	0.95 ± 0.13	0.92 ± 0.21	0.387
HDL-C (mmol/L)	1.60 ± 0.10	1.63 ± 0.08	0.174
LDL-C (mmol/L)	2.56 ± 0.14	2.52 ± 0.18	0.225

Abbreviations: PCOS: polycystic ovary syndrome; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; FINS: fasting insulin; HOMA-IR: homeostasis model assessment of insulin resistance; LH: luteinizing hormone; FSH: follicle-stimulating hormone; E₂: estradiol; T: testosterone; PRL: prolactin; P: progesterone; AMH: anti-mullerian hormone; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol. Data are presented as mean ± standard deviation (SD).

ISSN: 1472-6874